Developments on the generic front

1. Teva and Medicis settled Solodyn case after Teva's at-risk launch. Teva ceased shipping, was relived by Medicis from any claim, but would launch again in 2011 or earlier, under certain circumstances.

2. Impax started co-promoting Pristiq as part of the Effexor XR settlement.